Lista de obras - Paola Nisticò - Dominio Público Uruguay

3D models in the new era of immune oncology: focus on T cells, CAF and ECM

artículo científico publicado en 2019

A cytofluorimetric assay to evaluate T cell polyfunctionality

scientific article published on 14 August 2019

Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell lines.

artículo científico publicado en 1997

Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis

artículo científico publicado en 2017

An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen

artículo científico publicado en 2009

Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patients

scientific article published on 11 September 2018

Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models

scientific article published on 06 September 2013

Autoantibody signature in human ductal pancreatic adenocarcinoma.

artículo científico publicado en 2007

Biological mechanisms linked to inflammation in cancer: Discovery of tumor microenvironment-related biomarkers and their clinical application in solid tumors

artículo científico publicado en 2020

Cell retargeting by bispecific monoclonal antibodies. Evidence of bypass of intratumor susceptibility to cell lysis in human melanoma ⬇️

artículo científico publicado el 1 de septiembre de 1992

Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients.

artículo científico publicado en 2009

Circulating Autoantibodies to Phosphorylated α-Enolase are a Hallmark of Pancreatic Cancer

artículo científico publicado en 2010

Combination of chemotherapy and PD-1 blockade induces T cell responses to tumor non-mutated neoantigens

artículo científico publicado en 2020

Combinations of immuno-checkpoint inhibitors predictive biomarkers only marginally improve their individual accuracy

scientific article published on 23 April 2019

Corrigendum to "Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring"

artículo científico publicado en 2020

Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage

artículo científico publicado en 2020

Dacarbazine treatment before peptide vaccination enlarges T-cell repertoire diversity of melan-a-specific, tumor-reactive CTL in melanoma patients.

artículo científico publicado en 2010

Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting

artículo científico publicado en 2017

Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases

artículo científico publicado en 2012

Gene transfer by retrovirus-derived shuttle vectors in the generation of murine bispecific monoclonal antibodies.

artículo científico publicado en 1990

Generation and characterization of two human alpha/beta T cell clones. Recognizing autologous breast tumor cells through an HLA- and TCR/CD3-independent pathway.

artículo científico publicado en 1994

Host immunosurveillance contributes to the control of erbB-2 overexpression in HLA-A2-breast-cancer patients

scientific article published on 01 December 1999

Human Mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune response

artículo científico publicado en 2004

Human Mena+11a isoform serves as a marker of epithelial phenotype and sensitivity to epidermal growth factor receptor inhibition in human pancreatic cancer cell lines

artículo científico publicado en 2008

IL-18 receptor marks functional CD8+ T cells in non-small cell lung cancer

artículo científico publicado en 2017

Identification of invasion specific splice variants of the cytoskeletal protein Mena present in mammary tumor cells during invasion in vivo.

artículo científico publicado en 2008

Low Frequency of ErbB-2 Proto-oncogene Overexpression in Human Leukocyte Antigen-A2-Positive Breast Cancer Patients

artículo científico publicado en 1997

Melan-A/MART-1 Antigen Expression in Cutaneous and Ocular Melanomas ⬇️

artículo científico publicado el 1 de noviembre de 1997

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

artículo científico publicado en 2016

Modulation of the antigenic phenotype of early-passage human melanoma cells derived from multiple autologous metastases by recombinant human leukocyte, fibroblast and immune interferon

scientific article published on 01 September 1990

Molecular and genetic bases of pancreatic cancer.

artículo científico

Molecular cloning of hMena (ENAH) and its splice variant hMena+11a: epidermal growth factor increases their expression and stimulates hMena+11a phosphorylation in breast cancer cell lines.

artículo científico publicado en 2007

Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring

scientific article published on 12 April 2020

Mutant p53 gains new function in promoting inflammatory signals by repression of the secreted interleukin-1 receptor antagonist.

artículo científico publicado en 2014

Polyclonal Antibodies Against gp185HER2 Peptides: Their Putative Role in the Identification of a Particular HER2 Status in Patients With Breast Cancer

artículo científico publicado en 2001

Polyfunctional Melan-A-specific tumor-reactive CD8(+) T cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS.

artículo científico publicado en 2016

Polyphenols: Immunomodulatory and Therapeutic Implication in Colorectal Cancer

artículo científico publicado en 2019

Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer.

artículo científico publicado en 2014

Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors

artículo científico publicado en 2012

The actin modulator hMENA regulates GAS6-AXL axis and pro-tumor cancer/stromal cell cooperation

scientific article published on 10 September 2020

The cooperation between hMena overexpression and HER2 signalling in breast cancer

artículo científico publicado en 2010

The cytoskeleton regulatory protein hMena (ENAH) is overexpressed in human benign breast lesions with high risk of transformation and human epidermal growth factor receptor-2-positive/hormonal receptor-negative tumors.

artículo científico publicado en 2006

The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome

artículo científico publicado en 2016

Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

artículo científico publicado en 2019

hMENA is a key regulator in endothelin-1/β-arrestin1-induced invadopodial function and metastatic process.

artículo científico publicado en 2018

hMENA isoforms impact NSCLC patient outcome through fibronectin/β1 integrin axis

scientific article published on 15 June 2018

hMENA(11a) contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells.

artículo científico publicado en 2015

hMENA(11a), a hMENA isoform sending survival signals

artículo científico publicado en 2015

β1 and β4 integrins: from breast development to clinical practice

artículo científico publicado en 2014

Lista de obras de Paola Nisticò

3D models in the new era of immune oncology: focus on T cells, CAF and ECM

A cytofluorimetric assay to evaluate T cell polyfunctionality

Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell lines.

Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis

An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen

Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patients

Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models

Autoantibody signature in human ductal pancreatic adenocarcinoma.

Biological mechanisms linked to inflammation in cancer: Discovery of tumor microenvironment-related biomarkers and their clinical application in solid tumors

Cell retargeting by bispecific monoclonal antibodies. Evidence of bypass of intratumor susceptibility to cell lysis in human melanoma ⬇️

Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients.

Circulating Autoantibodies to Phosphorylated α-Enolase are a Hallmark of Pancreatic Cancer

Combination of chemotherapy and PD-1 blockade induces T cell responses to tumor non-mutated neoantigens

Combinations of immuno-checkpoint inhibitors predictive biomarkers only marginally improve their individual accuracy

Corrigendum to "Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring"

Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage

Dacarbazine treatment before peptide vaccination enlarges T-cell repertoire diversity of melan-a-specific, tumor-reactive CTL in melanoma patients.

Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting

Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases

Gene transfer by retrovirus-derived shuttle vectors in the generation of murine bispecific monoclonal antibodies.

Generation and characterization of two human alpha/beta T cell clones. Recognizing autologous breast tumor cells through an HLA- and TCR/CD3-independent pathway.

Host immunosurveillance contributes to the control of erbB-2 overexpression in HLA-A2-breast-cancer patients

Human Mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune response

Human Mena+11a isoform serves as a marker of epithelial phenotype and sensitivity to epidermal growth factor receptor inhibition in human pancreatic cancer cell lines

IL-18 receptor marks functional CD8+ T cells in non-small cell lung cancer

Identification of invasion specific splice variants of the cytoskeletal protein Mena present in mammary tumor cells during invasion in vivo.

Low Frequency of ErbB-2 Proto-oncogene Overexpression in Human Leukocyte Antigen-A2-Positive Breast Cancer Patients

Melan-A/MART-1 Antigen Expression in Cutaneous and Ocular Melanomas ⬇️

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

Modulation of the antigenic phenotype of early-passage human melanoma cells derived from multiple autologous metastases by recombinant human leukocyte, fibroblast and immune interferon

Molecular and genetic bases of pancreatic cancer.

Molecular cloning of hMena (ENAH) and its splice variant hMena+11a: epidermal growth factor increases their expression and stimulates hMena+11a phosphorylation in breast cancer cell lines.

Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring

Mutant p53 gains new function in promoting inflammatory signals by repression of the secreted interleukin-1 receptor antagonist.

Polyclonal Antibodies Against gp185HER2 Peptides: Their Putative Role in the Identification of a Particular HER2 Status in Patients With Breast Cancer

Polyfunctional Melan-A-specific tumor-reactive CD8(+) T cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS.

Polyphenols: Immunomodulatory and Therapeutic Implication in Colorectal Cancer

Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer.

Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors

The actin modulator hMENA regulates GAS6-AXL axis and pro-tumor cancer/stromal cell cooperation

The cooperation between hMena overexpression and HER2 signalling in breast cancer

The cytoskeleton regulatory protein hMena (ENAH) is overexpressed in human benign breast lesions with high risk of transformation and human epidermal growth factor receptor-2-positive/hormonal receptor-negative tumors.

The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome

Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

hMENA is a key regulator in endothelin-1/β-arrestin1-induced invadopodial function and metastatic process.

hMENA isoforms impact NSCLC patient outcome through fibronectin/β1 integrin axis

hMENA(11a) contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells.

hMENA(11a), a hMENA isoform sending survival signals

β1 and β4 integrins: from breast development to clinical practice